Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1984 3
1985 7
1986 1
1989 1
1990 5
1994 2
1995 1
1996 1
1997 1
2000 1
2001 1
2002 1
2003 5
2004 10
2005 7
2006 5
2007 11
2008 11
2009 7
2010 9
2011 13
2012 17
2013 22
2014 23
2015 15
2016 9
2017 11
2018 9
2019 9
2020 3
2021 5
2022 8
2023 10
2024 6
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and Safety of Elafibranor in Primary Biliary Cholangitis.
Kowdley KV, Bowlus CL, Levy C, Akarca US, Alvares-da-Silva MR, Andreone P, Arrese M, Corpechot C, Francque SM, Heneghan MA, Invernizzi P, Jones D, Kruger FC, Lawitz E, Mayo MJ, Shiffman ML, Swain MG, Valera JM, Vargas V, Vierling JM, Villamil A, Addy C, Dietrich J, Germain JM, Mazain S, Rafailovic D, Taddé B, Miller B, Shu J, Zein CO, Schattenberg JM; ELATIVE Study Investigators’ Group; ELATIVE Study Investigators' Group. Kowdley KV, et al. N Engl J Med. 2024 Feb 29;390(9):795-805. doi: 10.1056/NEJMoa2306185. Epub 2023 Nov 13. N Engl J Med. 2024. PMID: 37962077 Clinical Trial.
Diagnosis and Management of Hepatitis Delta Virus Infection.
Pan C, Gish R, Jacobson IM, Hu KQ, Wedemeyer H, Martin P. Pan C, et al. Among authors: jacobson im. Dig Dis Sci. 2023 Aug;68(8):3237-3248. doi: 10.1007/s10620-023-07960-y. Epub 2023 Jun 20. Dig Dis Sci. 2023. PMID: 37338616 Free PMC article. Review.
Diagnosis and Management of Primary Biliary Cholangitis.
Younossi ZM, Bernstein D, Shiffman ML, Kwo P, Kim WR, Kowdley KV, Jacobson IM. Younossi ZM, et al. Among authors: jacobson im. Am J Gastroenterol. 2019 Jan;114(1):48-63. doi: 10.1038/s41395-018-0390-3. Am J Gastroenterol. 2019. PMID: 30429590 Review.
Editorial: bodybuilders beware.
Feldman DM, Jacobson IM. Feldman DM, et al. Among authors: jacobson im. Aliment Pharmacol Ther. 2019 Jun;49(12):1530. doi: 10.1111/apt.15270. Aliment Pharmacol Ther. 2019. PMID: 31134650 No abstract available.
Fenofibrate-induced cirrhosis.
Ahmed F, Petrovic L, Rosen E, Gonzalez R, Jacobson IM. Ahmed F, et al. Among authors: jacobson im. Dig Dis Sci. 2005 Feb;50(2):312-3. doi: 10.1007/s10620-005-1600-6. Dig Dis Sci. 2005. PMID: 15745090 Review. No abstract available.
Viral hepatitis vaccines.
Jacobson IM, Dienstag JL. Jacobson IM, et al. Annu Rev Med. 1985;36:241-61. doi: 10.1146/annurev.me.36.020185.001325. Annu Rev Med. 1985. PMID: 3922284 Review.
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial.
Yuen MF, Asselah T, Jacobson IM, Brunetto MR, Janssen HLA, Takehara T, Hou JL, Kakuda TN, Lambrecht T, Beumont M, Kalmeijer R, Guinard-Azadian C, Mayer C, Jezorwski J, Verbinnen T, Lenz O, Shukla U, Biermer M; REEF-1 Study Group. Yuen MF, et al. Among authors: jacobson im. Lancet Gastroenterol Hepatol. 2023 Sep;8(9):790-802. doi: 10.1016/S2468-1253(23)00148-6. Epub 2023 Jul 10. Lancet Gastroenterol Hepatol. 2023. PMID: 37442152 Clinical Trial.
The Liver in Systemic Disease.
Liapakis A, Jacobson IM. Liapakis A, et al. Among authors: jacobson im. Clin Liver Dis. 2025 Aug;29(3):xiii-xv. doi: 10.1016/j.cld.2025.05.001. Epub 2025 May 26. Clin Liver Dis. 2025. PMID: 40670039 No abstract available.
New potent HBV replication inhibitors for the management of chronic hepatitis B are needed.
Block TM, Guo JT, Zoulim F, Rice CM, Thio CL, Schneider WM, Alter HJ, Jacobson IM, Gish RG, Block PD, Sulkowski M, Feld JJ, Cohen CA. Block TM, et al. Among authors: jacobson im. Nat Rev Gastroenterol Hepatol. 2025 Mar;22(3):150-151. doi: 10.1038/s41575-025-01037-z. Nat Rev Gastroenterol Hepatol. 2025. PMID: 39910374 No abstract available.
Safety and efficacy of elafibranor in primary sclerosing cholangitis: The ELMWOOD phase II randomized-controlled trial.
Levy C, Abouda GF, Bilir BM, Bonder A, Bowlus CL, Campos-Varela I, Cazzagon N, Chandok N, Cheent K, Cortez-Pinto H, Demir M, Dill MT, Eksteen B, Fenkel JM, Gilroy R, Ko HH, Jacobson IM, Kallis Y, Kugelmas M, Luketic V, Mangia A, Montano-Loza AJ, Mukhopadhya A, Olveira A, Patel BC, Pietrangelo A, Pradhan F, Salcedo M, Shiffman ML, Sprinzl K, Swann R, Thorburn D, Thuluvath PJ, Trivedi PJ, Turnes J, Zein CO, Gomes da Silva H, Jaitly S, Miller B, Milligan C, Tavenard A, Kowdley KV. Levy C, et al. Among authors: jacobson im. J Hepatol. 2025 May 8:S0168-8278(25)00252-1. doi: 10.1016/j.jhep.2025.04.025. Online ahead of print. J Hepatol. 2025. PMID: 40350321 Free article.
225 results